Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Vanda Pharmaceuticals Ltd withdraws its marketing-authorisation application for Fanaptum (iloperidone) 14 Marec 2013Press releaseCorporate 14 March 2013: World Kidney Day: 'Acute kidney injury: stop kidney attack!' 13 Marec 2013NewsCorporate European Medicines Agency focuses on new legislation, increased efficiency and transparency in 2013 work programme 13 Marec 2013NewsCorporateMedicines Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 March 2013 8 Marec 2013Press releaseVeterinary Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 March 2013 8 Marec 2013NewsHumanPharmacovigilance EU agencies to advise on risks from phenylbutazone in horsemeat 7 Marec 2013NewsCorporate Public consultation starts on first guideline on medicines for the treatment of lupus erythematous 5 Marec 2013NewsCorporateRegulatory and procedural guidance Tackling medication errors: European Medicines Agency workshop calls for coordinated EU approach 1 Marec 2013Press releaseCorporateMedicines 28 February 2013 - Rare Disease Day: 'Rare disorders without borders' 27 Februar 2013NewsCorporate Anika Therapeutics S.r.l. withdraws its marketing-authorisation application for Hyalograft C autograft 27 Februar 2013Press releaseCorporate 1 … 233 234 235 236 237 Page 237 of 384 238 239 240 241 … 384
Vanda Pharmaceuticals Ltd withdraws its marketing-authorisation application for Fanaptum (iloperidone) 14 Marec 2013Press releaseCorporate
14 March 2013: World Kidney Day: 'Acute kidney injury: stop kidney attack!' 13 Marec 2013NewsCorporate
European Medicines Agency focuses on new legislation, increased efficiency and transparency in 2013 work programme 13 Marec 2013NewsCorporateMedicines
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 March 2013 8 Marec 2013Press releaseVeterinary
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 March 2013 8 Marec 2013NewsHumanPharmacovigilance
Public consultation starts on first guideline on medicines for the treatment of lupus erythematous 5 Marec 2013NewsCorporateRegulatory and procedural guidance
Tackling medication errors: European Medicines Agency workshop calls for coordinated EU approach 1 Marec 2013Press releaseCorporateMedicines
Anika Therapeutics S.r.l. withdraws its marketing-authorisation application for Hyalograft C autograft 27 Februar 2013Press releaseCorporate